Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02191982 · ClinicalTrials.gov registry record · NA

The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older

A NA study of Cancer and Fatigue, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT02191982 is a NA study of Cancer and Fatigue that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 44 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02191982, a NA study of Cancer and Fatigue, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

This study will look at the impact of a self-directed walking program on post-chemotherapy survivors experiencing fatigue. It is hypothesized that the walking program will help lessen fatigue.

Interventions

  • BEHAVIORAL Walk With Ease

Study Locations (1)

North Carolina

  • University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2014-06
Est. Completion 2017-08
Phase NA

What the Registry Record Tells You About NCT02191982

The ClinicalTrials.gov registry entry for NCT02191982 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Walk With Ease is the first listed.

NCT02191982 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02191982 about?

NCT02191982 is a clinical study titled "The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older". This study will look at the impact of a self-directed walking program on post-chemotherapy survivors experiencing fatigue. It is hypothesized that the walking program will help lessen fatigue.

What is the current status of trial NCT02191982?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2014-06. Estimated completion is 2017-08.

What conditions does trial NCT02191982 study?

This clinical trial studies the following conditions: Cancer, Fatigue, Geriatric.

What interventions are being tested in trial NCT02191982?

The interventions under investigation include: Walk With Ease (BEHAVIORAL).

Who is sponsoring clinical trial NCT02191982?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02191982 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.